510(k) Report

FDA applicant

Focal Therapeutics

Portola Valley, CA5 decisions2012–20193 recalls

FDA records 5 decisions for Focal Therapeutics (Portola Valley, CA) from 2012 to 2019: 5 510(k) clearances. Most are in product codes NEU (Marker, Radiographic, Implantable) and IYE (Accelerator, Linear, Medical). Its devices cite 15 predicates, 6 of them its own earlier devices. 3 recalls are linked to its devices, 2 Class I.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, general and plastic surgery panel, where it files most

How often FDA has decided Focal Therapeutics’s devices, and how often a recall has named them.

FDA decisions per year

1in 2019

2012: 12015: 22017: 12019: 1
2012high 2 (2015) · low 0 (2013)2026

2026 so far, outlined.

Recalls per year

2in 2024

2022: 12024: 2, 2 Class I
2012high 2 (2024) · low 0 (2012)2026

Class I Class II/III not classified

FIG. 1 — Focal Therapeutics by year, 2012–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Focal Therapeutics’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Other applicant names beginning “Focal”

FDA records each applicant name separately; these may or may not be the same firm.